BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27335291)

  • 1. [Changes of 2015 WHO Histological Classification of Lung Cancer 
and the Clinical Significance].
    Yang X; Lin D
    Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):332-6. PubMed ID: 27335291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
    Travis WD; Brambilla E; Nicholson AG; Yatabe Y; Austin JHM; Beasley MB; Chirieac LR; Dacic S; Duhig E; Flieder DB; Geisinger K; Hirsch FR; Ishikawa Y; Kerr KM; Noguchi M; Pelosi G; Powell CA; Tsao MS; Wistuba I;
    J Thorac Oncol; 2015 Sep; 10(9):1243-1260. PubMed ID: 26291008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Grading of lung cancer].
    Bohle RM; Schnabel PA
    Pathologe; 2016 Jul; 37(4):314-9. PubMed ID: 27356985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New WHO classification of lung adenocarcinoma and preneoplasia].
    Lantuejoul S; Rouquette I; Brambilla E; Travis WD
    Ann Pathol; 2016 Jan; 36(1):5-14. PubMed ID: 26791238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
    Rodriguez EF; Monaco SE; Dacic S
    Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
    Travis WD; Brambilla E; Riely GJ
    J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsolid pulmonary nodules: CT-pathologic correlation using the 2011 IASLC/ATS/ERS classification.
    Liao JH; Amin VB; Kadoch MA; Beasley MB; Jacobi AH
    Clin Imaging; 2015; 39(3):344-51. PubMed ID: 25709110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia.
    Franklin WA
    Chest; 2000 Apr; 117(4 Suppl 1):80S-89S. PubMed ID: 10777460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.
    Revannasiddaiah S; Thakur P; Bhardwaj B; Susheela SP; Madabhavi I
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S502-25. PubMed ID: 25349702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comments on International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma (2011)].
    Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):793-6. PubMed ID: 22336202
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
    Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
    J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
    Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
    Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
    Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
    J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).
    Tang ER; Schreiner AM; Pua BB
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S489-501. PubMed ID: 25349701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
    Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D
    Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.